Herpes Virus Infection Is Associated with Vascular Remodeling and Pulmonary Hypertension in Idiopathic Pulmonary Fibrosis

PLoS ONE

Volumn 8, Issue 2, 2013, Pages

  Calabrese, Fiorella ^a   Kipar, Anja ^b,c   Lunardi, Francesca ^a   Balestro, Elisabetta ^a   Perissinotto, Egle ^a   Rossi, Emanuela ^a   Nannini, Nazarena ^a   Marulli, Giuseppe ^a   Stewart, James P ^b   Rea, Federico ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL WALL THICKENING; ARTICLE; CELL PROLIFERATION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FIBROSING ALVEOLITIS; GENOME ANALYSIS; HERPES VIRUS INFECTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG ALVEOLUS EPITHELIUM; LUNG ARTERY PRESSURE; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MOLECULAR DYNAMICS; NICK END LABELING; NONHUMAN; OUTCOME ASSESSMENT; PATIENT ASSESSMENT; PRESSURE MEASUREMENT; PRIMARY GRAFT DYSFUNCTION; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; VIRUS GENOME; VIRUS IDENTIFICATION; WALKING;

ANIMALS; ARTERIAL PRESSURE; BLOOD VESSELS; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; FEMALE; GENOME, VIRAL; HERPESVIRIDAE; HERPESVIRIDAE INFECTIONS; HUMANS; HYPERTENSION, PULMONARY; IDIOPATHIC PULMONARY FIBROSIS; LUNG; LUNG TRANSPLANTATION; MALE; MICE; MIDDLE AGED; PNEUMOCYTES; PULMONARY ARTERY; TRANSFORMING GROWTH FACTOR BETA;

EID: 84874511371     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055715     Document Type: Article

References (58)

1. American Thoracic Society, European Respiratory Society (2002) American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors, June 2001 and by the ERS Executive Committee, June 2001. Am J Respir Crit Care Med 165: 277-304.
2. Raghu G, Weycker D, Edelsberg J, Bradford WZ, Oster G, (2006) Incidence and prevalence of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 174: 810-816.
3. King TE Jr, Pardo A, Selman M, (2011) Idiopathic pulmonary fibrosis. Lancet 378: 1949-1961.
4. Whelan TP, Dunitz JM, Kelly RF, Edwards LB, Herrington CS, et al. (2005) Effect of preoperative pulmonary artery pressure on early survival after lung transplantation for idiopathic pulmonary fibrosis. J Heart Lung Transplant 24: 1269-1274.
5. Nadrous HF, Pellikka PA, Krowka MJ, Swanson KL, Chaowalit N, et al. (2005) The impact of pulmonary hypertension on survival in patients with idiopathic pulmonary fibrosis. Chest 128: 616S-617S.
6. Lettieri CJ, Nathan SD, Barnett SD, Ahmad S, Shorr AF, (2006) Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest 129: 746-752.
7. Patel NM, Lederer DJ, Borczuk AC, Kawut SM, (2007) Pulmonary hypertension in idiopathic pulmonary fibrosis. Chest 132: 998-1006.
8. Leuchte HH, Neurohr C, Baumgartner R, Holzapfel M, Giehrl W, et al. (2004) Brain natriuretic peptide and exercise capacity in lung fibrosis and pulmonary hypertention. Am J Respir Crit Care Med 170: 360-365.
9. Zisman DA, Karlamangla AS, Ross DJ, Keane MP, Belperio JA, et al. (2007) High-resolution chest CT findings do not predict the presence of pulmonary hypertension in advanced idiopathic pulmonary fibrosis. Chest 132: 773-779.
10. Selman M, King TE, Pardo A, (2001) American Thoracic Society, European Respiratory Society, et al (2001) American College of Chest Physicians. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 134: 136-151.
11. Ebina M, Shimizukawa M, Shibata N, Kimura Y, Suzuki T, et al. (2004) Heterogeneous increase in CD34-positive alveolar capillaries in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 169: 1203-1208.
12. Nathan SD, Noble PW, Tuder RM, (2007) Idiopathic pulmonary fibrosis and pulmonary hypertension: connecting the dots. Am J Respir Crit Care Med 175: 875-880.
13. Farkas L, Farkas D, Ask K, Möller A, Gauldie J, et al. (2009) VEGF ameliorates pulmonary hypertension through inhibition of endothelial apoptosis in experimental lung fibrosis in rats. J Clin Invest 119: 1298-1311.
14. Farkas L, Gauldie J, Voelkel NF, Kolb M, (2011) Pulmonary hypertension and idiopathic pulmonary fibrosis: a tale of angiogenesis, apoptosis, and growth factors. Am J Respir Cell Mol Biol 45: 1-15.
15. Egan JJ, Stewart JP, Hasleton PS, Arrand JR, Carroll KB, et al. (1995) Epstein-Barr virus replication within pulmonary epithelial cells in cryptogenic fibrosing alveolitis. Thorax 50: 1234-1239.
16. Kuwano K, Nomoto Y, Kunitake R, Hagimoto N, Matsuba T, et al. (1997) Detection of adenovirus E1A DNA in pulmonary fibrosis using nested polymerase chain reaction. Eur Respir J 10: 1445-1449.
17. Stewart JP, Egan JJ, Ross AJ, Kelly BG, Lok SS, et al. (1999) The detection of Epstein-Barr virus DNA in lung tissue from patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 159: 1336-1341.
18. Kelly BG, Lok SS, Hasleton PS, Egan JJ, Stewart JP, (2002) A rearranged form of Epstein-Barr virus DNA is associated with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 166: 510-513.
19. Lok SS, Haider Y, Howell D, Stewart JP, Hasleton PS, et al. (2002) Murine gammaherpes virus as a cofactor in the development of pulmonary fibrosis in bleomycin resistant mice. Eur Respir J 20: 1228-1232.
20. Tang YW, Johnson JE, Browning PJ, Cruz-Gervis RA, Davis A, et al. (2003) Herpesvirus DNA is consistently detected in lungs of patients with idiopathic pulmonary fibrosis. J Clin Microbiol 41: 2633-2640.
21. Zamò A, Poletti V, Reghellin D, Montagna L, Pedron S, et al. (2005) HHV-8 and EBV are not commonly found in idiopathic pulmonary fibrosis. Sarcoidosis Vasc Diffuse Lung Dis 22: 123-128.
22. Mora AL, Woods CR, Garcia A, Xu J, Rojas M, et al. (2005) Lung infection with gamma-Herpes virus induces progressive pulmonary fibrosis in Th2-biased mice. Am J Physiol Lung Cell Mol Physiol 289: L711-721.
23. Mora AL, Torres-González E, Rojas M, Corredor C, Ritzenthaler J, et al. (2006) Activation of alveolar macrophages via the alternative pathway in Herpes virus-induced lung fibrosis. Am J Respir Cell Mol Biol 35: 466-473.
24. Mora AL, Torres-González E, Rojas M, Xu J, Ritzenthaler J, et al. (2007) Control of virus reactivation arrests pulmonary Herpes virus-induced fibrosis in IFN-gamma receptor-deficient mice. Am J Respir Crit Care Med 175: 1139-1150.
25. McMillan TR, Moore BB, Weinberg JB, Vannella KM, Fields WB, et al. (2008) Exacerbation of established pulmonary fibrosis in a murine model by gammaHerpes virus. Am J Respir Crit Care Med 177: 771-780.
26. Arase Y, Suzuki F, Suzuki Y, Akuta N, Kobayashi M, et al. (2008) Hepatitis C virus enhances incidence of idiopathic pulmonary fibrosis. World J Gastroenterol 14: 5880-5886.
27. Malizia AP, Keating DT, Smith SM, Walls D, Doran PP, et al. (2008) Alveolar epithelial cell injury with Epstein-Barr virus up-regulates TGFbeta1 expression. Am J Physiol Lung Cell Mol Physiol 295: L451-460.
28. Pozharskaya V, Torres-González E, Rojas M, Gal A, Amin M, et al. (2009) Twist: a regulator of epithelial-mesenchymal transition in lung fibrosis. PLoS One 4: e7559.
29. Malizia AP, Egan JJ, Doran PP, (2009) IL-4 increases CD21-dependent infection of pulmonary alveolar epithelial type II cells by EBV. Mol Immunol 46: 1905-1910.
30. Malizia AP, Lacey N, Walls D, Egan JJ, Doran PP, (2009) CUX1/Wnt signaling regulates epithelial mesenchymal transition in EBV infected epithelial cells. Exp Cell Res 315: 1819-1831.
31. Pulkkinen V, Bruce S, Rintahaka J, Hodgson U, Laitinen T, et al. (2010) ELMOD2, a candidate gene for idiopathic pulmonary fibrosis, regulates antiviral responses. FASEB J 24: 1167-1177.
32. Vannella KM, Luckhardt TR, Wilke CA, van Dyk LF, Toews GB, et al. (2010) Latent Herpes virus infection augments experimental pulmonary fibrosis. Am J Respir Crit Care Med 181: 465-477.
33. Sides MD, Klingsberg RC, Shan B, Gordon KA, Nguyen HT, et al. (2011) The Epstein-Barr virus latent membrane protein 1 and transforming growth factor-β1 synergistically induce epithelial-mesenchymal transition in lung epithelial cells. Am J Respir Cell Mol Biol 44: 852-862.
34. Pulkkinen V, Salmenkivi K, Kinnula VL, Sutinen E, Halme M, et al. (2012) A novel screening method detects herpesviral DNA in the idiopathic pulmonary fibrosis lung. Ann Med 44: 178-186.
35. Egan JJ, Adamali HI, Lok SS, Stewart JP, Woodcock AA, (2011) Ganciclovir antiviral therapy in advanced idiopathic pulmonary fibrosis: an open pilot study. Pulm Med 2011: 240805.
36. Christie JD, Carby M, Bag R, Corris P, Hertz M, et al. (2005) Report of the ISHLT working group on primary lung graft dysfunction: Part II. Definition. J Heart Lung Transplant 24: 1454-1459.
37. Stewart S, Fishbein MC, Snell GI, Berry GJ, Boehler A, et al. (2007) Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant 26: 1229-1242.
38. Chomczynski P, Sacchi N, (2006) The single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction: twenty-something years on. Nat Protoc 1: 581-585.
39. Calabrese F, Rizzo S, Giacometti C, Panizzolo C, Turato G, et al. (2008) High viral frequency in children with gastroesophageal reflux-related chronic respiratory disorders. Pediatr Pulmonol 43: 690-696.
40. Ercolani L, Florence B, Denaro M, Alexander M, (1988) Isolation and complete sequence of glyceraldehyde-3-phosphate dehydrogenase gene. J Biol Chem 263: 1535-1541.
41. Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, et al. (1985) Enzymatic amplification of beta globin genomic sequence and restriction site analysis for diagnosis of sickle cell anemia. Science 230: 13450-13454.
42. Kwok S, Higuchi R, (1989) Avoiding false positives with PCR. Nature 339: 237-238.
43. Calabrese F, Angelini A, Thiene G, Basso C, Nava A, et al. (2000) No detection of enteroviral genome in the myocardium of patients with arrhythmogenic right ventricular cardiomyopathy. J Clin Pathol 53: 382-387.
44. Lunardi F, Calabrese F, Furian L, Rigotti P, Valente M, (2011) Epstein-Barr Virus-Associated Gastric Carcinoma Thirthy-Three Years After Kidney Transplantation. NDT Plus 4: 49-52.
45. Calabrese F, Lunardi F, Giacometti C, Marulli G, Gnoato M, et al. (2008) Overexpression of squamous cell carcinoma antigen in idiopathic pulmonary fibrosis: clinicopathological correlations. Thorax 63: 795-802.
46. Delgado JF, Conde E, Sánchez V, López-Ríos F, Gómez-Sánchez MA, et al. (2005) Pulmonary vascular remodeling in pulmonary hypertension due to chronic heart failure. Eur J Heart Fail 7: 1011-1016.
47. Calabrese F, Giacometti C, Beghe B, Rea F, Loy M, et al. (2005) Marked alveolar apoptosis/proliferation imbalance in end-stage emphysema. Respir Res. 6: 14.
48. Egan J, Stewart J, Yonan N, Arrand J, Woodcock A, (1994) Non-Hodgkin lymphoma in heart/lung transplant recipients. Lancet 343: 481.
49. Zhang J, Yu KF, (1998) What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA 280: 1690-1691.
50. Payne CM, Heggie CJ, Brownstein DG, Stewart JP, Quinn JP, (2001) Role of Tachykinins in the Host Response to Murine GammaHerpes virus Infection. Journal of Virology 75: 10467-10471.
51. Tsukamoto K, Hayakawa H, Sato A, Chida K, Nakamura H, et al. (2000) Involvement of Epstein-Barr virus latent membrane protein 1 in disease progression in patients with idiopathic pulmonary fibrosis. Thorax 55: 958-961.
52. Cooper LT Jr, (2009) Myocarditis. N Engl J Med 360: 1526-1538.
53. Lung ML, Lam WK, So SY, Lam WP, Chan KH, et al. (1985) Evidence that respiratory tract is major reservoir for Epstein-Barr virus. Lancet 1: 889-892.
54. Hansson GK, Robertson AK, Söderberg-Nauclér C, (2006) Inflammation and atherosclerosis. Annu Rev Pathol 1: 297-329.
55. Cool CD, Rai PR, Yeager ME, Hernandez-Saavedra D, Serls AE, et al. (2003) Expression of human herpesvirus 8 in primary pulmonary hypertension. N Engl J Med 349: 1113-1122.
56. Williams KJ, Maes R, Del Piero F, Lim A, Wise A, et al. (2007) Equine Multinodular Pulmonary Fibrosis: A Newly Recognized Herpes virus-Associated Fibrotic Lung Disease. Vet Pathol 44: 849-862.
57. Suarez AL, van Dyk LF, (2008) Endothelial Cells Support Persistent Gammaherpesvirus 68 Infection. PLoS Pathog 4: e1000152.
58. Mihira H, Suzuki HI, Akatsu Y, Yoshimatsu Y, Igarashi T, et al. (2012) TGF-{beta}-induced mesenchymal transition of MS-1 endothelial cells requires Smad-dependent cooperative activation of Rho signals and MRTF-A. J Biochem 151: 145-156.